EX-FILING FEES 5 ny20010094x1_ex107.htm FILING FEES TABLE

Exhibit 107

Calculation of Filing Fee Tables

Schedule TO
(Form Type)

PARDES BIOSCIENCES, INC.
(Name of Subject Company (Issuer))

MEDIPACIFIC SUB, INC.
(Name of Filing Person — Offeror)
a wholly-owned subsidiary of

MEDIPACIFIC, INC.
(Name of Filing Person — Parent of Offeror)
an affiliate of

FS DEVELOPMENT HOLDINGS II, LLC,
FORESITE CAPITAL MANAGEMENT V, LLC,
FORESITE CAPITAL OPPORTUNITY FUND V, L.P.,
FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC,
FORESITE CAPITAL FUND V, L.P. and
JAMES TANANBAUM
(Names of Filing Persons — Other)

Table 1 – Transaction Value

 
Transaction
Valuation
Fee rate
Amount of Filing Fee
Fees to Be Paid
$132,350,817.00 (1)
.0001102
$14,585.06 (2)
Fees Previously Paid
$136,088,312.78
 
$14,996.93
Total Transaction Valuation
$132,350,817.00
   
Total Fees Due for Filing
   
$14,585.06
Total Fees Previously Paid
   
$14,996.93
Total Fee Offsets
   
$14,585.06
Net Fee Due
   
$0.00


 
(1)
Estimated solely for the purpose of calculating the filing fee. The transaction value was calculated by adding (i) the product of (a) $2.13, which is the price per share of common stock of Pardes Biosciences, Inc. (the “Company”) (each, a “Share”), and (b) 62,054,756 Shares issued and outstanding (including restricted Shares) and (ii) the product of (a) the difference between (1) $2.13 and (2) an exercise price of $2.04 (the weighted-average exercise price of the outstanding options) and (b) stock options representing the right to purchase an aggregate of 1,935,408. The calculation of the transaction value is based on information provided by the Company as of August 15, 2023.
 
 
 
 
(2)
The amount of the filing fee was calculated by multiplying the transaction value by 0.0001102.

Table 2 – Fee Offset Claims and Sources

 
Registrant or Filer Name
Form or Filing Type
File Number
Initial Filing Date
Filing Date
Fee Offset Claimed
Fee Paid with Fee Offset Source
Fee Offset Claims
 
Schedule TO
231123926
July 28, 2023
 
$14,585.06
 
Fee Offset Sources
MediPacific Sub, Inc; MediPacific, Inc.; FS Development Holdings II, LLC; Foresite Capital Management V, LLC; Foresite Capital Opportunity Fund V, L.P.; Foresite Capital Opportunity Management V, LLC; Foresite Capital Fund V, L.P.; James Tananbaum
Schedule TO
231123926
 
July 28, 2023
 
$14,585.06